Dublin, Ohio-based Cardinal Health is nearing a deal with Minneapolis-based Medtronic to acquire its medical supplies business for approximately $6 billion, an unnamed source told Reuters Wednesday.

Medtronic ended its fiscal year with nominal sales growth and a steep profit drop, but analysts who cover the medical device company are confident a windfall is ahead, thanks to a strong lineup of ...

Minneapolis-based Medtronic is preparing to sell part or all of its medical supplies business, an unnamed source told Bloomberg. While Medtronic has sought prospective buyers for the unit, ...

Medtronic MDT posted solid fiscal first-quarter results that held few surprises and put the firm on track to meet our full-year expectations. We’re leaving our $112 fair value estimate unchanged, and ...

Bloomberg reports that Medtronic (NYSE:MDT) is working with advisors on the sale of its medical supplies business, a unit that could fetch as much as $5B if sold in its entirety. Shares are up 1% ...

Medtronic’s (NYSE: MDT) diabetes segment, which sells insulin pumps, continuous glucose monitoring systems, and consumables has seen its revenue rise at a slower pace of 1.4% annually from $2.4 ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to an ...